209 related articles for article (PubMed ID: 4073878)
1. Comparative trial of rifampin-doxycycline versus tetracycline-streptomycin in the therapy of human brucellosis.
Ariza J; Gudiol F; Pallarés R; Rufí G; Fernández-Viladrich P
Antimicrob Agents Chemother; 1985 Oct; 28(4):548-51. PubMed ID: 4073878
[TBL] [Abstract][Full Text] [Related]
2. Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A randomized, double-blind study.
Ariza J; Gudiol F; Pallares R; Viladrich PF; Rufi G; Corredoira J; Miravitlles MR
Ann Intern Med; 1992 Jul; 117(1):25-30. PubMed ID: 1596044
[TBL] [Abstract][Full Text] [Related]
3. Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas.
Solera J; Rodríguez-Zapata M; Geijo P; Largo J; Paulino J; Sáez L; Martínez-Alfaro E; Sánchez L; Sepulveda MA; Ruiz-Ribó MD
Antimicrob Agents Chemother; 1995 Sep; 39(9):2061-7. PubMed ID: 8540716
[TBL] [Abstract][Full Text] [Related]
4. Comparative trial of doxycycline plus streptomycin versus doxycycline plus rifampin for the therapy of human brucellosis.
Colmenero Castillo JD; Hernandez Marquez S; Reguera Iglesias JM; Cabrera Franquelo F; Rius Diaz F; Alonso A
Chemotherapy; 1989; 35(2):146-52. PubMed ID: 2667903
[TBL] [Abstract][Full Text] [Related]
5. Comparison of five antimicrobial regimens for the treatment of brucellar spondylitis: a prospective, randomized study.
Bayindir Y; Sonmez E; Aladag A; Buyukberber N
J Chemother; 2003 Oct; 15(5):466-71. PubMed ID: 14598939
[TBL] [Abstract][Full Text] [Related]
6. [A comparative therapeutic and multicenter trial of rifampicin and doxycycline versus streptomycin and doxycycline in human brucellosis].
Solera J; Medrano F; Rodríguez M; Geijo P; Paulino J
Med Clin (Barc); 1991 May; 96(17):649-53. PubMed ID: 1905372
[TBL] [Abstract][Full Text] [Related]
7. Comparison of doxycycline-streptomycin, doxycycline-rifampin, and ofloxacin-rifampin in the treatment of brucellosis: a randomized clinical trial.
Hashemi SH; Gachkar L; Keramat F; Mamani M; Hajilooi M; Janbakhsh A; Majzoobi MM; Mahjub H
Int J Infect Dis; 2012 Apr; 16(4):e247-51. PubMed ID: 22296864
[TBL] [Abstract][Full Text] [Related]
8. Doxycycline plus streptomycin versus ciprofloxacin plus rifampicin in spinal brucellosis [ISRCTN31053647].
Alp E; Koc RK; Durak AC; Yildiz O; Aygen B; Sumerkan B; Doganay M
BMC Infect Dis; 2006 Apr; 6():72. PubMed ID: 16606473
[TBL] [Abstract][Full Text] [Related]
9. Administration of a triple versus a standard double antimicrobial regimen for human brucellosis more efficiently eliminates bacterial DNA load.
Vrioni G; Bourdakis A; Pappas G; Pitiriga V; Mavrouli M; Pournaras S; Tsakris A
Antimicrob Agents Chemother; 2014 Dec; 58(12):7541-4. PubMed ID: 25246401
[TBL] [Abstract][Full Text] [Related]
10. Comparison between doxycycline-rifampin-amikacin and doxycycline-rifampin regimens in the treatment of brucellosis.
Ranjbar M; Keramat F; Mamani M; Kia AR; Khalilian FO; Hashemi SH; Nojomi M
Int J Infect Dis; 2007 Mar; 11(2):152-6. PubMed ID: 16798042
[TBL] [Abstract][Full Text] [Related]
11. Therapy of experimental murine brucellosis with streptomycin alone and in combination with ciprofloxacin, doxycycline, and rifampin.
Lang R; Shasha B; Rubinstein E
Antimicrob Agents Chemother; 1993 Nov; 37(11):2333-6. PubMed ID: 8285615
[TBL] [Abstract][Full Text] [Related]
12. Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis.
Ariza J; Bosch J; Gudiol F; Liñares J; Viladrich PF; Martín R
Antimicrob Agents Chemother; 1986 Dec; 30(6):958-60. PubMed ID: 3813520
[TBL] [Abstract][Full Text] [Related]
13. Multicenter prospective study of treatment of Brucella melitensis brucellosis with doxycycline for 6 weeks plus streptomycin for 2 weeks.
Cisneros JM; Viciana P; Colmenero J; Pachón J; Martinez C; Alarcón A
Antimicrob Agents Chemother; 1990 May; 34(5):881-3. PubMed ID: 2193624
[TBL] [Abstract][Full Text] [Related]
14. Early clinical response to different therapeutic regimens for human brucellosis.
Malik GM
Am J Trop Med Hyg; 1998 Feb; 58(2):190-1. PubMed ID: 9502602
[TBL] [Abstract][Full Text] [Related]
15. Possible implications of doxycycline-rifampin interaction for treatment of brucellosis.
Colmenero JD; Fernández-Gallardo LC; Agúndez JA; Sedeño J; Benítez J; Valverde E
Antimicrob Agents Chemother; 1994 Dec; 38(12):2798-802. PubMed ID: 7695265
[TBL] [Abstract][Full Text] [Related]
16. Quinolones in treatment of human brucellosis: comparative trial of ofloxacin-rifampin versus doxycycline-rifampin.
Akova M; Uzun O; Akalin HE; Hayran M; Unal S; Gür D
Antimicrob Agents Chemother; 1993 Sep; 37(9):1831-4. PubMed ID: 8239591
[TBL] [Abstract][Full Text] [Related]
17. Ofloxacin plus rifampicin versus doxycycline plus rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179].
Karabay O; Sencan I; Kayas D; Sahin I
BMC Infect Dis; 2004 Jun; 4():18. PubMed ID: 15214959
[TBL] [Abstract][Full Text] [Related]
18. Comparison of three different regimens in the treatment of acute brucellosis: a multicenter multinational study.
Acocella G; Bertrand A; Beytout J; Durrande JB; Garcia Rodriguez JA; Kosmidis J; Micoud M; Rey M; Rodriguez Zapata M; Roux J
J Antimicrob Chemother; 1989 Mar; 23(3):433-9. PubMed ID: 2732125
[TBL] [Abstract][Full Text] [Related]
19. Doxycycline-rifampin versus doxycycline-rifampin-gentamicin in treatment of human brucellosis.
Mile B; Valerija K; Krsto G; Ivan V; Ilir D; Nikola L
Trop Doct; 2012 Jan; 42(1):13-7. PubMed ID: 22290107
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of gentamicin plus doxycycline versus streptomycin plus doxycycline in the treatment of brucellosis in humans.
Hasanjani Roushan MR; Mohraz M; Hajiahmadi M; Ramzani A; Valayati AA
Clin Infect Dis; 2006 Apr; 42(8):1075-80. PubMed ID: 16575723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]